Skip to main content
OpenTrials

Clinical trial condition

Epithelial Ovarian Cancer

Explore clinical trials studying Epithelial Ovarian Cancer. Study availability and eligibility vary by location and protocol.

142 public trials 36 recruiting studies
Refine in advanced search Browse all conditions

Epithelial Ovarian Cancer trial results

Completed

Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

NCT04539327

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Hospital Torrecárdenas Almería, Andalusia, Spain
  • Hospital Universitario Virgen de la Victoria Málaga, Andalusia, Spain
  • Hospital Universitario Virgen del Rocío Seville, Andalusia, Spain
  • Hospital Universitario Nuestra Señora de Valme Seville, Andalusia, Spain
View all 23 locations
View Trial Details
Completed

RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

NCT06173037

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
View all 30 locations
View Trial Details
Completed

Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers

NCT05483933

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
Locations
  • University of Arkansas for Medical sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Robert H.Lurie ComprehensiveCancer Center, Northwestern University Chicago, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 21 locations
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details
Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

NCT04925284

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Exelixis Clinical Site #48 Birmingham, Alabama, United States
  • Exelixis Clinical Site #20 Tucson, Arizona, United States
  • Exelixis Clinical Site#95 Tucson, Arizona, United States
  • Exelixis Clinical Site#58 Little Rock, Arkansas, United States
View all 95 locations
View Trial Details
Completed

Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer

NCT02480374

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • University of Alabama Birmingham Cancer Center Birmingham, Alabama, United States
  • Washington Univ. in St. Louis/Barnes Jewish Hospital St Louis, Missouri, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Medical College of Wisconsin/Froedtert Hospital Milwaukee, Wisconsin, United States
View Trial Details

Related conditions